nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomefloxacin—TOP2A—breast cancer	0.314	1	CbGaD
Lomefloxacin—TOP2A—Idarubicin—breast cancer	0.132	0.291	CbGbCtD
Lomefloxacin—TOP2A—Mitoxantrone—breast cancer	0.0567	0.125	CbGbCtD
Lomefloxacin—TOP2A—Epirubicin—breast cancer	0.0459	0.101	CbGbCtD
Lomefloxacin—CYP1A2—Anastrozole—breast cancer	0.0266	0.0588	CbGbCtD
Lomefloxacin—TOP2A—Doxorubicin—breast cancer	0.0244	0.0539	CbGbCtD
Lomefloxacin—CYP1A2—Toremifene—breast cancer	0.0243	0.0538	CbGbCtD
Lomefloxacin—ABCC2—Tamoxifen—breast cancer	0.0239	0.0527	CbGbCtD
Lomefloxacin—ABCC2—Paclitaxel—breast cancer	0.0186	0.041	CbGbCtD
Lomefloxacin—ABCC2—Irinotecan—breast cancer	0.0183	0.0404	CbGbCtD
Lomefloxacin—ABCC2—Carboplatin—breast cancer	0.0175	0.0386	CbGbCtD
Lomefloxacin—ABCC2—Vinblastine—breast cancer	0.0163	0.036	CbGbCtD
Lomefloxacin—ABCC2—Docetaxel—breast cancer	0.0134	0.0296	CbGbCtD
Lomefloxacin—ABCC2—Doxorubicin—breast cancer	0.01	0.0221	CbGbCtD
Lomefloxacin—ABCC2—Methotrexate—breast cancer	0.00969	0.0214	CbGbCtD
Lomefloxacin—CYP1A2—Tamoxifen—breast cancer	0.00889	0.0196	CbGbCtD
Lomefloxacin—CYP1A2—Fluorouracil—breast cancer	0.00655	0.0145	CbGbCtD
Lomefloxacin—TOP2A—nipple—breast cancer	0.000919	0.104	CbGeAlD
Lomefloxacin—Trovafloxacin—TOP2A—breast cancer	0.000647	0.167	CrCbGaD
Lomefloxacin—SLC22A5—mammary gland—breast cancer	0.000588	0.0668	CbGeAlD
Lomefloxacin—TOP2A—endometrium—breast cancer	0.000555	0.063	CbGeAlD
Lomefloxacin—TOP2A—uterus—breast cancer	0.000511	0.0581	CbGeAlD
Lomefloxacin—TOP2A—adipose tissue—breast cancer	0.0005	0.0568	CbGeAlD
Lomefloxacin—Moxifloxacin—TOP2A—breast cancer	0.000491	0.126	CrCbGaD
Lomefloxacin—SLC22A5—nipple—breast cancer	0.000487	0.0553	CbGeAlD
Lomefloxacin—TOP2A—adrenal gland—breast cancer	0.000449	0.0509	CbGeAlD
Lomefloxacin—CYP1A2—nipple—breast cancer	0.000441	0.0501	CbGeAlD
Lomefloxacin—TOP2A—bone marrow—breast cancer	0.000434	0.0493	CbGeAlD
Lomefloxacin—TOP2A—female gonad—breast cancer	0.000418	0.0475	CbGeAlD
Lomefloxacin—TOP2A—Docetaxel—Paclitaxel—breast cancer	0.000385	0.121	CbGdCrCtD
Lomefloxacin—TOP2A—Gefitinib—Lapatinib—breast cancer	0.000377	0.118	CbGdCrCtD
Lomefloxacin—Pefloxacin—TOP2A—breast cancer	0.000358	0.0921	CrCbGaD
Lomefloxacin—Enoxacin—TOP2A—breast cancer	0.000335	0.0861	CrCbGaD
Lomefloxacin—ABCC2—female reproductive system—breast cancer	0.000314	0.0357	CbGeAlD
Lomefloxacin—SLC22A5—skin of body—breast cancer	0.000312	0.0354	CbGeAlD
Lomefloxacin—Sparfloxacin—TOP2A—breast cancer	0.000308	0.0792	CrCbGaD
Lomefloxacin—ABCC2—adrenal gland—breast cancer	0.000307	0.0348	CbGeAlD
Lomefloxacin—SLC22A5—endometrium—breast cancer	0.000294	0.0334	CbGeAlD
Lomefloxacin—Ofloxacin—ABCC1—breast cancer	0.000281	0.0723	CrCbGaD
Lomefloxacin—TOP2A—Topotecan—Irinotecan—breast cancer	0.000274	0.0857	CbGdCrCtD
Lomefloxacin—TOP2A—lymph node—breast cancer	0.000269	0.0305	CbGeAlD
Lomefloxacin—SLC22A5—pituitary gland—breast cancer	0.000266	0.0302	CbGeAlD
Lomefloxacin—ABCC2—endocrine gland—breast cancer	0.000266	0.0302	CbGeAlD
Lomefloxacin—SLC22A5—adipose tissue—breast cancer	0.000265	0.0301	CbGeAlD
Lomefloxacin—TOP2A—Vindesine—Vinorelbine—breast cancer	0.000245	0.0766	CbGdCrCtD
Lomefloxacin—SLC22A5—female reproductive system—breast cancer	0.000243	0.0276	CbGeAlD
Lomefloxacin—SLC22A5—adrenal gland—breast cancer	0.000238	0.027	CbGeAlD
Lomefloxacin—SLC22A5—female gonad—breast cancer	0.000221	0.0251	CbGeAlD
Lomefloxacin—Levofloxacin—TOP2A—breast cancer	0.000217	0.0558	CrCbGaD
Lomefloxacin—Ofloxacin—TOP2A—breast cancer	0.000217	0.0558	CrCbGaD
Lomefloxacin—Ciprofloxacin—TOP2A—breast cancer	0.000209	0.0539	CrCbGaD
Lomefloxacin—TOP2A—Vindesine—Vinblastine—breast cancer	0.000196	0.0613	CbGdCrCtD
Lomefloxacin—TOP2A—Paclitaxel—Docetaxel—breast cancer	0.000192	0.0602	CbGdCrCtD
Lomefloxacin—CYP1A2—endocrine gland—breast cancer	0.000187	0.0212	CbGeAlD
Lomefloxacin—ABCC2—lymph node—breast cancer	0.000184	0.0209	CbGeAlD
Lomefloxacin—Norfloxacin—TOP2A—breast cancer	0.000176	0.0452	CrCbGaD
Lomefloxacin—SLC22A5—lymph node—breast cancer	0.000142	0.0162	CbGeAlD
Lomefloxacin—Gatifloxacin—ALB—breast cancer	0.000141	0.0362	CrCbGaD
Lomefloxacin—TOP2A—Doxorubicin—Idarubicin—breast cancer	0.00014	0.0439	CbGdCrCtD
Lomefloxacin—TOP2A—Epirubicin—Idarubicin—breast cancer	0.00014	0.0439	CbGdCrCtD
Lomefloxacin—TOP2A—Daunorubicin—Idarubicin—breast cancer	0.00014	0.0439	CbGdCrCtD
Lomefloxacin—TOP2A—Vincristine—Vinorelbine—breast cancer	0.000132	0.0413	CbGdCrCtD
Lomefloxacin—TOP2A—Vinorelbine—Vinblastine—breast cancer	0.000123	0.0387	CbGdCrCtD
Lomefloxacin—TOP2A—Vinblastine—Vinorelbine—breast cancer	0.000106	0.0333	CbGdCrCtD
Lomefloxacin—TOP2A—Vincristine—Vinblastine—breast cancer	0.000105	0.0331	CbGdCrCtD
Lomefloxacin—Norfloxacin—CYP1A1—breast cancer	9.41e-05	0.0242	CrCbGaD
Lomefloxacin—TOP2A—Methyltestosterone—Fluoxymesterone—breast cancer	8.88e-05	0.0278	CbGdCrCtD
Lomefloxacin—Sparfloxacin—ABCB1—breast cancer	8.76e-05	0.0225	CrCbGaD
Lomefloxacin—Levofloxacin—CYP3A4—breast cancer	7.41e-05	0.0191	CrCbGaD
Lomefloxacin—Ciprofloxacin—CYP3A4—breast cancer	7.15e-05	0.0184	CrCbGaD
Lomefloxacin—TOP2A—Cytarabine—Gemcitabine—breast cancer	6.93e-05	0.0217	CbGdCrCtD
Lomefloxacin—TOP2A—Idarubicin—Epirubicin—breast cancer	6.43e-05	0.0201	CbGdCrCtD
Lomefloxacin—TOP2A—Doxorubicin—Epirubicin—breast cancer	6.43e-05	0.0201	CbGdCrCtD
Lomefloxacin—TOP2A—Daunorubicin—Epirubicin—breast cancer	6.43e-05	0.0201	CbGdCrCtD
Lomefloxacin—Levofloxacin—ABCB1—breast cancer	6.17e-05	0.0159	CrCbGaD
Lomefloxacin—Norfloxacin—CYP3A4—breast cancer	6.01e-05	0.0155	CrCbGaD
Lomefloxacin—Ciprofloxacin—ABCB1—breast cancer	5.95e-05	0.0153	CrCbGaD
Lomefloxacin—TOP2A—Epirubicin—Doxorubicin—breast cancer	5.95e-05	0.0186	CbGdCrCtD
Lomefloxacin—TOP2A—Idarubicin—Doxorubicin—breast cancer	5.95e-05	0.0186	CbGdCrCtD
Lomefloxacin—TOP2A—Daunorubicin—Doxorubicin—breast cancer	5.95e-05	0.0186	CbGdCrCtD
Lomefloxacin—TOP2A—Norethindrone—Fluoxymesterone—breast cancer	5.79e-05	0.0181	CbGdCrCtD
Lomefloxacin—TOP2A—Azacitidine—Gemcitabine—breast cancer	4.97e-05	0.0156	CbGdCrCtD
Lomefloxacin—TOP2A—Cell Cycle—HSP90AA1—breast cancer	3.32e-05	0.000522	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	3.27e-05	0.000515	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC5A5—breast cancer	3.21e-05	0.000505	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	3.19e-05	0.000502	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	3.19e-05	0.000501	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—BRCA1—breast cancer	3.18e-05	0.000501	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	3.18e-05	0.0005	CbGpPWpGaD
Lomefloxacin—Epistaxis—Doxorubicin—breast cancer	3.16e-05	0.000205	CcSEcCtD
Lomefloxacin—Anorexia—Capecitabine—breast cancer	3.16e-05	0.000205	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	3.15e-05	0.000496	CbGpPWpGaD
Lomefloxacin—Vomiting—Irinotecan—breast cancer	3.15e-05	0.000205	CcSEcCtD
Lomefloxacin—Vomiting—Mitoxantrone—breast cancer	3.15e-05	0.000205	CcSEcCtD
Lomefloxacin—Dizziness—Fluorouracil—breast cancer	3.13e-05	0.000204	CcSEcCtD
Lomefloxacin—Visual impairment—Epirubicin—breast cancer	3.13e-05	0.000204	CcSEcCtD
Lomefloxacin—Agranulocytosis—Doxorubicin—breast cancer	3.12e-05	0.000203	CcSEcCtD
Lomefloxacin—Rash—Irinotecan—breast cancer	3.12e-05	0.000203	CcSEcCtD
Lomefloxacin—Rash—Mitoxantrone—breast cancer	3.12e-05	0.000203	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CCNE1—breast cancer	3.12e-05	0.00049	CbGpPWpGaD
Lomefloxacin—Dermatitis—Mitoxantrone—breast cancer	3.12e-05	0.000203	CcSEcCtD
Lomefloxacin—Dermatitis—Irinotecan—breast cancer	3.12e-05	0.000203	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Docetaxel—breast cancer	3.12e-05	0.000203	CcSEcCtD
Lomefloxacin—Chills—Methotrexate—breast cancer	3.11e-05	0.000203	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC2A1—breast cancer	3.1e-05	0.000488	CbGpPWpGaD
Lomefloxacin—Headache—Irinotecan—breast cancer	3.1e-05	0.000202	CcSEcCtD
Lomefloxacin—Headache—Mitoxantrone—breast cancer	3.1e-05	0.000202	CcSEcCtD
Lomefloxacin—Hypotension—Capecitabine—breast cancer	3.1e-05	0.000201	CcSEcCtD
Lomefloxacin—Insomnia—Docetaxel—breast cancer	3.09e-05	0.000201	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	3.08e-05	0.000485	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	3.07e-05	0.000484	CbGpPWpGaD
Lomefloxacin—Paraesthesia—Docetaxel—breast cancer	3.07e-05	0.0002	CcSEcCtD
Lomefloxacin—Erythema multiforme—Epirubicin—breast cancer	3.07e-05	0.0002	CcSEcCtD
Lomefloxacin—Vomiting—Gemcitabine—breast cancer	3.07e-05	0.000199	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—TYMS—breast cancer	3.06e-05	0.000482	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SYNJ2—breast cancer	3.06e-05	0.000481	CbGpPWpGaD
Lomefloxacin—Bradycardia—Doxorubicin—breast cancer	3.06e-05	0.000199	CcSEcCtD
Lomefloxacin—CYP1A2—Phase II conjugation—GSTM1—breast cancer	3.06e-05	0.000481	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—JUN—breast cancer	3.05e-05	0.00048	CbGpPWpGaD
Lomefloxacin—Dyspnoea—Docetaxel—breast cancer	3.05e-05	0.000198	CcSEcCtD
Lomefloxacin—Somnolence—Docetaxel—breast cancer	3.04e-05	0.000198	CcSEcCtD
Lomefloxacin—Rash—Gemcitabine—breast cancer	3.04e-05	0.000198	CcSEcCtD
Lomefloxacin—Dermatitis—Gemcitabine—breast cancer	3.04e-05	0.000197	CcSEcCtD
Lomefloxacin—Tinnitus—Epirubicin—breast cancer	3.03e-05	0.000197	CcSEcCtD
Lomefloxacin—Headache—Gemcitabine—breast cancer	3.02e-05	0.000196	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—breast cancer	3.02e-05	0.000475	CbGpPWpGaD
Lomefloxacin—Musculoskeletal discomfort—Capecitabine—breast cancer	3.02e-05	0.000196	CcSEcCtD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—ALB—breast cancer	3.02e-05	0.000474	CbGpPWpGaD
Lomefloxacin—Flushing—Epirubicin—breast cancer	3.01e-05	0.000196	CcSEcCtD
Lomefloxacin—Vomiting—Fluorouracil—breast cancer	3.01e-05	0.000196	CcSEcCtD
Lomefloxacin—Rhinitis—Doxorubicin—breast cancer	3.01e-05	0.000196	CcSEcCtD
Lomefloxacin—Dyspepsia—Docetaxel—breast cancer	3.01e-05	0.000196	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	3.01e-05	0.000473	CbGpPWpGaD
Lomefloxacin—Hepatitis—Doxorubicin—breast cancer	3.01e-05	0.000195	CcSEcCtD
Lomefloxacin—CYP1A2—Tryptophan metabolism—MDM2—breast cancer	3e-05	0.000472	CbGpPWpGaD
Lomefloxacin—Insomnia—Capecitabine—breast cancer	3e-05	0.000195	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—breast cancer	2.99e-05	0.000471	CbGpPWpGaD
Lomefloxacin—Rash—Fluorouracil—breast cancer	2.99e-05	0.000194	CcSEcCtD
Lomefloxacin—Dermatitis—Fluorouracil—breast cancer	2.99e-05	0.000194	CcSEcCtD
Lomefloxacin—Pharyngitis—Doxorubicin—breast cancer	2.98e-05	0.000194	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RELA—breast cancer	2.98e-05	0.000469	CbGpPWpGaD
Lomefloxacin—Paraesthesia—Capecitabine—breast cancer	2.97e-05	0.000193	CcSEcCtD
Lomefloxacin—Decreased appetite—Docetaxel—breast cancer	2.97e-05	0.000193	CcSEcCtD
Lomefloxacin—Hypersensitivity—Paclitaxel—breast cancer	2.97e-05	0.000193	CcSEcCtD
Lomefloxacin—Headache—Fluorouracil—breast cancer	2.97e-05	0.000193	CcSEcCtD
Lomefloxacin—Dysgeusia—Methotrexate—breast cancer	2.96e-05	0.000192	CcSEcCtD
Lomefloxacin—Dyspnoea—Capecitabine—breast cancer	2.95e-05	0.000192	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—PTEN—breast cancer	2.95e-05	0.000464	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—MTR—breast cancer	2.95e-05	0.000464	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—H2AFX—breast cancer	2.95e-05	0.000464	CbGpPWpGaD
Lomefloxacin—Fatigue—Docetaxel—breast cancer	2.95e-05	0.000192	CcSEcCtD
Lomefloxacin—Nausea—Mitoxantrone—breast cancer	2.94e-05	0.000191	CcSEcCtD
Lomefloxacin—Nausea—Irinotecan—breast cancer	2.94e-05	0.000191	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC2A2—breast cancer	2.93e-05	0.000461	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—E2F1—breast cancer	2.93e-05	0.000461	CbGpPWpGaD
Lomefloxacin—Constipation—Docetaxel—breast cancer	2.93e-05	0.00019	CcSEcCtD
Lomefloxacin—Back pain—Methotrexate—breast cancer	2.92e-05	0.00019	CcSEcCtD
Lomefloxacin—Dyspepsia—Capecitabine—breast cancer	2.92e-05	0.00019	CcSEcCtD
Lomefloxacin—Chills—Epirubicin—breast cancer	2.91e-05	0.00019	CcSEcCtD
Lomefloxacin—Arrhythmia—Epirubicin—breast cancer	2.9e-05	0.000189	CcSEcCtD
Lomefloxacin—Visual impairment—Doxorubicin—breast cancer	2.9e-05	0.000188	CcSEcCtD
Lomefloxacin—Asthenia—Paclitaxel—breast cancer	2.9e-05	0.000188	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—breast cancer	2.89e-05	0.000455	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—HPGDS—breast cancer	2.89e-05	0.000455	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—MAPK8—breast cancer	2.89e-05	0.000454	CbGpPWpGaD
Lomefloxacin—Decreased appetite—Capecitabine—breast cancer	2.88e-05	0.000187	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—BRCA2—breast cancer	2.88e-05	0.000453	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ABCG2—breast cancer	2.87e-05	0.000451	CbGpPWpGaD
Lomefloxacin—Nausea—Gemcitabine—breast cancer	2.86e-05	0.000186	CcSEcCtD
Lomefloxacin—Fatigue—Capecitabine—breast cancer	2.86e-05	0.000186	CcSEcCtD
Lomefloxacin—Pruritus—Paclitaxel—breast cancer	2.86e-05	0.000186	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	2.85e-05	0.000448	CbGpPWpGaD
Lomefloxacin—Erythema multiforme—Doxorubicin—breast cancer	2.84e-05	0.000185	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—NCOA1—breast cancer	2.84e-05	0.000446	CbGpPWpGaD
Lomefloxacin—Constipation—Capecitabine—breast cancer	2.83e-05	0.000184	CcSEcCtD
Lomefloxacin—Feeling abnormal—Docetaxel—breast cancer	2.82e-05	0.000183	CcSEcCtD
Lomefloxacin—Nausea—Fluorouracil—breast cancer	2.82e-05	0.000183	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—GSTT1—breast cancer	2.81e-05	0.000441	CbGpPWpGaD
Lomefloxacin—Ill-defined disorder—Methotrexate—breast cancer	2.8e-05	0.000182	CcSEcCtD
Lomefloxacin—Tinnitus—Doxorubicin—breast cancer	2.8e-05	0.000182	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Docetaxel—breast cancer	2.8e-05	0.000182	CcSEcCtD
Lomefloxacin—Anaemia—Methotrexate—breast cancer	2.79e-05	0.000182	CcSEcCtD
Lomefloxacin—Flushing—Doxorubicin—breast cancer	2.79e-05	0.000181	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—CCNE1—breast cancer	2.79e-05	0.000439	CbGpPWpGaD
Lomefloxacin—Flatulence—Epirubicin—breast cancer	2.79e-05	0.000181	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	2.78e-05	0.000437	CbGpPWpGaD
Lomefloxacin—Tension—Epirubicin—breast cancer	2.77e-05	0.00018	CcSEcCtD
Lomefloxacin—Dysgeusia—Epirubicin—breast cancer	2.77e-05	0.00018	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—PLG—breast cancer	2.77e-05	0.000435	CbGpPWpGaD
Lomefloxacin—Diarrhoea—Paclitaxel—breast cancer	2.76e-05	0.00018	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—breast cancer	2.75e-05	0.000433	CbGpPWpGaD
Lomefloxacin—Nervousness—Epirubicin—breast cancer	2.75e-05	0.000179	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—breast cancer	2.74e-05	0.000431	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—breast cancer	2.74e-05	0.000431	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—TYMS—breast cancer	2.74e-05	0.000431	CbGpPWpGaD
Lomefloxacin—Back pain—Epirubicin—breast cancer	2.74e-05	0.000178	CcSEcCtD
Lomefloxacin—Feeling abnormal—Capecitabine—breast cancer	2.73e-05	0.000178	CcSEcCtD
Lomefloxacin—Malaise—Methotrexate—breast cancer	2.72e-05	0.000177	CcSEcCtD
Lomefloxacin—Muscle spasms—Epirubicin—breast cancer	2.72e-05	0.000177	CcSEcCtD
Lomefloxacin—Vertigo—Methotrexate—breast cancer	2.71e-05	0.000177	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Capecitabine—breast cancer	2.71e-05	0.000176	CcSEcCtD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—breast cancer	2.71e-05	0.000426	CbGpPWpGaD
Lomefloxacin—Abdominal pain—Docetaxel—breast cancer	2.7e-05	0.000176	CcSEcCtD
Lomefloxacin—Leukopenia—Methotrexate—breast cancer	2.7e-05	0.000176	CcSEcCtD
Lomefloxacin—Chills—Doxorubicin—breast cancer	2.7e-05	0.000175	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—breast cancer	2.69e-05	0.000424	CbGpPWpGaD
Lomefloxacin—Arrhythmia—Doxorubicin—breast cancer	2.69e-05	0.000175	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—breast cancer	2.68e-05	0.000422	CbGpPWpGaD
Lomefloxacin—Dizziness—Paclitaxel—breast cancer	2.67e-05	0.000174	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—CYP17A1—breast cancer	2.66e-05	0.000418	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—H2AFX—breast cancer	2.64e-05	0.000415	CbGpPWpGaD
Lomefloxacin—Cough—Methotrexate—breast cancer	2.64e-05	0.000171	CcSEcCtD
Lomefloxacin—Urticaria—Capecitabine—breast cancer	2.63e-05	0.000171	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—PTGS1—breast cancer	2.63e-05	0.000414	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	2.63e-05	0.000413	CbGpPWpGaD
Lomefloxacin—Ill-defined disorder—Epirubicin—breast cancer	2.62e-05	0.000171	CcSEcCtD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP17A1—breast cancer	2.62e-05	0.000412	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—E2F1—breast cancer	2.62e-05	0.000412	CbGpPWpGaD
Lomefloxacin—Abdominal pain—Capecitabine—breast cancer	2.62e-05	0.00017	CcSEcCtD
Lomefloxacin—Convulsion—Methotrexate—breast cancer	2.62e-05	0.00017	CcSEcCtD
Lomefloxacin—Anaemia—Epirubicin—breast cancer	2.61e-05	0.00017	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—breast cancer	2.61e-05	0.00041	CbGpPWpGaD
Lomefloxacin—Agitation—Epirubicin—breast cancer	2.6e-05	0.000169	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—CYP2D6—breast cancer	2.58e-05	0.000406	CbGpPWpGaD
Lomefloxacin—Flatulence—Doxorubicin—breast cancer	2.58e-05	0.000168	CcSEcCtD
Lomefloxacin—Chest pain—Methotrexate—breast cancer	2.57e-05	0.000167	CcSEcCtD
Lomefloxacin—Myalgia—Methotrexate—breast cancer	2.57e-05	0.000167	CcSEcCtD
Lomefloxacin—Arthralgia—Methotrexate—breast cancer	2.57e-05	0.000167	CcSEcCtD
Lomefloxacin—Tension—Doxorubicin—breast cancer	2.57e-05	0.000167	CcSEcCtD
Lomefloxacin—Vomiting—Paclitaxel—breast cancer	2.57e-05	0.000167	CcSEcCtD
Lomefloxacin—Dysgeusia—Doxorubicin—breast cancer	2.56e-05	0.000167	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—TFRC—breast cancer	2.56e-05	0.000402	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	2.56e-05	0.000402	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—HMOX1—breast cancer	2.55e-05	0.000401	CbGpPWpGaD
Lomefloxacin—Malaise—Epirubicin—breast cancer	2.55e-05	0.000166	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	2.55e-05	0.000401	CbGpPWpGaD
Lomefloxacin—Rash—Paclitaxel—breast cancer	2.55e-05	0.000165	CcSEcCtD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP2D6—breast cancer	2.54e-05	0.0004	CbGpPWpGaD
Lomefloxacin—Dermatitis—Paclitaxel—breast cancer	2.54e-05	0.000165	CcSEcCtD
Lomefloxacin—Discomfort—Methotrexate—breast cancer	2.54e-05	0.000165	CcSEcCtD
Lomefloxacin—Nervousness—Doxorubicin—breast cancer	2.54e-05	0.000165	CcSEcCtD
Lomefloxacin—Vertigo—Epirubicin—breast cancer	2.54e-05	0.000165	CcSEcCtD
Lomefloxacin—Syncope—Epirubicin—breast cancer	2.54e-05	0.000165	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—NCOA2—breast cancer	2.53e-05	0.000398	CbGpPWpGaD
Lomefloxacin—Leukopenia—Epirubicin—breast cancer	2.53e-05	0.000165	CcSEcCtD
Lomefloxacin—Back pain—Doxorubicin—breast cancer	2.53e-05	0.000165	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—breast cancer	2.53e-05	0.000398	CbGpPWpGaD
Lomefloxacin—Headache—Paclitaxel—breast cancer	2.53e-05	0.000164	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDK2—breast cancer	2.53e-05	0.000397	CbGpPWpGaD
Lomefloxacin—Hypersensitivity—Docetaxel—breast cancer	2.52e-05	0.000164	CcSEcCtD
Lomefloxacin—Muscle spasms—Doxorubicin—breast cancer	2.52e-05	0.000164	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	2.5e-05	0.000393	CbGpPWpGaD
Lomefloxacin—Confusional state—Methotrexate—breast cancer	2.49e-05	0.000162	CcSEcCtD
Lomefloxacin—Loss of consciousness—Epirubicin—breast cancer	2.49e-05	0.000162	CcSEcCtD
Lomefloxacin—Cough—Epirubicin—breast cancer	2.47e-05	0.00016	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Methotrexate—breast cancer	2.47e-05	0.00016	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—BIRC5—breast cancer	2.46e-05	0.000387	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—NCOA2—breast cancer	2.46e-05	0.000387	CbGpPWpGaD
Lomefloxacin—Asthenia—Docetaxel—breast cancer	2.45e-05	0.00016	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—breast cancer	2.45e-05	0.000385	CbGpPWpGaD
Lomefloxacin—Convulsion—Epirubicin—breast cancer	2.45e-05	0.000159	CcSEcCtD
Lomefloxacin—Hypertension—Epirubicin—breast cancer	2.44e-05	0.000159	CcSEcCtD
Lomefloxacin—Hypersensitivity—Capecitabine—breast cancer	2.44e-05	0.000159	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Doxorubicin—breast cancer	2.43e-05	0.000158	CcSEcCtD
Lomefloxacin—Pruritus—Docetaxel—breast cancer	2.42e-05	0.000157	CcSEcCtD
Lomefloxacin—Anaemia—Doxorubicin—breast cancer	2.42e-05	0.000157	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Methotrexate—breast cancer	2.41e-05	0.000157	CcSEcCtD
Lomefloxacin—Myalgia—Epirubicin—breast cancer	2.41e-05	0.000157	CcSEcCtD
Lomefloxacin—Chest pain—Epirubicin—breast cancer	2.41e-05	0.000157	CcSEcCtD
Lomefloxacin—Arthralgia—Epirubicin—breast cancer	2.41e-05	0.000157	CcSEcCtD
Lomefloxacin—Agitation—Doxorubicin—breast cancer	2.4e-05	0.000156	CcSEcCtD
Lomefloxacin—Anxiety—Epirubicin—breast cancer	2.4e-05	0.000156	CcSEcCtD
Lomefloxacin—Nausea—Paclitaxel—breast cancer	2.4e-05	0.000156	CcSEcCtD
Lomefloxacin—Skin disorder—Methotrexate—breast cancer	2.4e-05	0.000156	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—breast cancer	2.39e-05	0.000376	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—TERT—breast cancer	2.39e-05	0.000375	CbGpPWpGaD
Lomefloxacin—Hyperhidrosis—Methotrexate—breast cancer	2.38e-05	0.000155	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	2.38e-05	0.000374	CbGpPWpGaD
Lomefloxacin—Discomfort—Epirubicin—breast cancer	2.38e-05	0.000155	CcSEcCtD
Lomefloxacin—Asthenia—Capecitabine—breast cancer	2.38e-05	0.000155	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	2.36e-05	0.000371	CbGpPWpGaD
Lomefloxacin—Malaise—Doxorubicin—breast cancer	2.36e-05	0.000153	CcSEcCtD
Lomefloxacin—Dry mouth—Epirubicin—breast cancer	2.35e-05	0.000153	CcSEcCtD
Lomefloxacin—Vertigo—Doxorubicin—breast cancer	2.35e-05	0.000153	CcSEcCtD
Lomefloxacin—Anorexia—Methotrexate—breast cancer	2.35e-05	0.000153	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC5A5—breast cancer	2.35e-05	0.000369	CbGpPWpGaD
Lomefloxacin—Syncope—Doxorubicin—breast cancer	2.35e-05	0.000153	CcSEcCtD
Lomefloxacin—Pruritus—Capecitabine—breast cancer	2.34e-05	0.000152	CcSEcCtD
Lomefloxacin—Leukopenia—Doxorubicin—breast cancer	2.34e-05	0.000152	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—breast cancer	2.34e-05	0.000368	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—breast cancer	2.34e-05	0.000368	CbGpPWpGaD
Lomefloxacin—Diarrhoea—Docetaxel—breast cancer	2.34e-05	0.000152	CcSEcCtD
Lomefloxacin—Confusional state—Epirubicin—breast cancer	2.33e-05	0.000151	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Epirubicin—breast cancer	2.31e-05	0.00015	CcSEcCtD
Lomefloxacin—Oedema—Epirubicin—breast cancer	2.31e-05	0.00015	CcSEcCtD
Lomefloxacin—Hypotension—Methotrexate—breast cancer	2.3e-05	0.00015	CcSEcCtD
Lomefloxacin—Loss of consciousness—Doxorubicin—breast cancer	2.3e-05	0.00015	CcSEcCtD
Lomefloxacin—Cough—Doxorubicin—breast cancer	2.28e-05	0.000148	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—breast cancer	2.28e-05	0.000359	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—CYP3A4—breast cancer	2.27e-05	0.000358	CbGpPWpGaD
Lomefloxacin—Shock—Epirubicin—breast cancer	2.27e-05	0.000148	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC2A1—breast cancer	2.27e-05	0.000357	CbGpPWpGaD
Lomefloxacin—Convulsion—Doxorubicin—breast cancer	2.27e-05	0.000147	CcSEcCtD
Lomefloxacin—Diarrhoea—Capecitabine—breast cancer	2.27e-05	0.000147	CcSEcCtD
Lomefloxacin—Dizziness—Docetaxel—breast cancer	2.26e-05	0.000147	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Epirubicin—breast cancer	2.26e-05	0.000147	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—CDK2—breast cancer	2.26e-05	0.000355	CbGpPWpGaD
Lomefloxacin—Hypertension—Doxorubicin—breast cancer	2.26e-05	0.000147	CcSEcCtD
Lomefloxacin—Tachycardia—Epirubicin—breast cancer	2.25e-05	0.000146	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Methotrexate—breast cancer	2.25e-05	0.000146	CcSEcCtD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP3A4—breast cancer	2.24e-05	0.000353	CbGpPWpGaD
Lomefloxacin—Skin disorder—Epirubicin—breast cancer	2.24e-05	0.000146	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—CYP1B1—breast cancer	2.24e-05	0.000352	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SLCO1B1—breast cancer	2.23e-05	0.000351	CbGpPWpGaD
Lomefloxacin—Hyperhidrosis—Epirubicin—breast cancer	2.23e-05	0.000145	CcSEcCtD
Lomefloxacin—Insomnia—Methotrexate—breast cancer	2.23e-05	0.000145	CcSEcCtD
Lomefloxacin—Arthralgia—Doxorubicin—breast cancer	2.23e-05	0.000145	CcSEcCtD
Lomefloxacin—Myalgia—Doxorubicin—breast cancer	2.23e-05	0.000145	CcSEcCtD
Lomefloxacin—Chest pain—Doxorubicin—breast cancer	2.23e-05	0.000145	CcSEcCtD
Lomefloxacin—Anxiety—Doxorubicin—breast cancer	2.22e-05	0.000144	CcSEcCtD
Lomefloxacin—Paraesthesia—Methotrexate—breast cancer	2.21e-05	0.000144	CcSEcCtD
Lomefloxacin—ABCC2—NRF2 pathway—TGFB1—breast cancer	2.21e-05	0.000348	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP1B1—breast cancer	2.21e-05	0.000347	CbGpPWpGaD
Lomefloxacin—Discomfort—Doxorubicin—breast cancer	2.2e-05	0.000143	CcSEcCtD
Lomefloxacin—Anorexia—Epirubicin—breast cancer	2.2e-05	0.000143	CcSEcCtD
Lomefloxacin—Dyspnoea—Methotrexate—breast cancer	2.2e-05	0.000143	CcSEcCtD
Lomefloxacin—Somnolence—Methotrexate—breast cancer	2.19e-05	0.000143	CcSEcCtD
Lomefloxacin—Dizziness—Capecitabine—breast cancer	2.19e-05	0.000142	CcSEcCtD
Lomefloxacin—Dry mouth—Doxorubicin—breast cancer	2.18e-05	0.000142	CcSEcCtD
Lomefloxacin—Vomiting—Docetaxel—breast cancer	2.18e-05	0.000141	CcSEcCtD
Lomefloxacin—Dyspepsia—Methotrexate—breast cancer	2.17e-05	0.000141	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	2.17e-05	0.000341	CbGpPWpGaD
Lomefloxacin—Rash—Docetaxel—breast cancer	2.16e-05	0.00014	CcSEcCtD
Lomefloxacin—Hypotension—Epirubicin—breast cancer	2.16e-05	0.00014	CcSEcCtD
Lomefloxacin—Dermatitis—Docetaxel—breast cancer	2.16e-05	0.00014	CcSEcCtD
Lomefloxacin—Confusional state—Doxorubicin—breast cancer	2.15e-05	0.00014	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—ATM—breast cancer	2.14e-05	0.000337	CbGpPWpGaD
Lomefloxacin—Decreased appetite—Methotrexate—breast cancer	2.14e-05	0.000139	CcSEcCtD
Lomefloxacin—Headache—Docetaxel—breast cancer	2.14e-05	0.000139	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—CDK4—breast cancer	2.14e-05	0.000336	CbGpPWpGaD
Lomefloxacin—Anaphylactic shock—Doxorubicin—breast cancer	2.14e-05	0.000139	CcSEcCtD
Lomefloxacin—Oedema—Doxorubicin—breast cancer	2.14e-05	0.000139	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—NCOA1—breast cancer	2.13e-05	0.000336	CbGpPWpGaD
Lomefloxacin—Fatigue—Methotrexate—breast cancer	2.13e-05	0.000138	CcSEcCtD
Lomefloxacin—Vomiting—Capecitabine—breast cancer	2.11e-05	0.000137	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Epirubicin—breast cancer	2.1e-05	0.000137	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—CYP19A1—breast cancer	2.1e-05	0.000331	CbGpPWpGaD
Lomefloxacin—Shock—Doxorubicin—breast cancer	2.1e-05	0.000137	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	2.1e-05	0.00033	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—breast cancer	2.1e-05	0.00033	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—breast cancer	2.09e-05	0.000329	CbGpPWpGaD
Lomefloxacin—Thrombocytopenia—Doxorubicin—breast cancer	2.09e-05	0.000136	CcSEcCtD
Lomefloxacin—Rash—Capecitabine—breast cancer	2.09e-05	0.000136	CcSEcCtD
Lomefloxacin—Insomnia—Epirubicin—breast cancer	2.09e-05	0.000136	CcSEcCtD
Lomefloxacin—Dermatitis—Capecitabine—breast cancer	2.09e-05	0.000136	CcSEcCtD
Lomefloxacin—Tachycardia—Doxorubicin—breast cancer	2.08e-05	0.000136	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—RB1—breast cancer	2.08e-05	0.000327	CbGpPWpGaD
Lomefloxacin—Headache—Capecitabine—breast cancer	2.08e-05	0.000135	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—NCOA1—breast cancer	2.08e-05	0.000326	CbGpPWpGaD
Lomefloxacin—Skin disorder—Doxorubicin—breast cancer	2.07e-05	0.000135	CcSEcCtD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP19A1—breast cancer	2.07e-05	0.000326	CbGpPWpGaD
Lomefloxacin—Paraesthesia—Epirubicin—breast cancer	2.07e-05	0.000135	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Doxorubicin—breast cancer	2.06e-05	0.000134	CcSEcCtD
Lomefloxacin—Dyspnoea—Epirubicin—breast cancer	2.06e-05	0.000134	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—breast cancer	2.05e-05	0.000323	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—breast cancer	2.05e-05	0.000323	CbGpPWpGaD
Lomefloxacin—Somnolence—Epirubicin—breast cancer	2.05e-05	0.000133	CcSEcCtD
Lomefloxacin—Anorexia—Doxorubicin—breast cancer	2.04e-05	0.000132	CcSEcCtD
Lomefloxacin—Nausea—Docetaxel—breast cancer	2.03e-05	0.000132	CcSEcCtD
Lomefloxacin—Feeling abnormal—Methotrexate—breast cancer	2.03e-05	0.000132	CcSEcCtD
Lomefloxacin—Dyspepsia—Epirubicin—breast cancer	2.03e-05	0.000132	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	2.03e-05	0.000319	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	2.03e-05	0.000319	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—PLG—breast cancer	2.02e-05	0.000318	CbGpPWpGaD
Lomefloxacin—Gastrointestinal pain—Methotrexate—breast cancer	2.02e-05	0.000131	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—TP53—breast cancer	2.01e-05	0.000317	CbGpPWpGaD
Lomefloxacin—Decreased appetite—Epirubicin—breast cancer	2.01e-05	0.00013	CcSEcCtD
Lomefloxacin—Hypotension—Doxorubicin—breast cancer	2e-05	0.00013	CcSEcCtD
Lomefloxacin—Fatigue—Epirubicin—breast cancer	1.99e-05	0.000129	CcSEcCtD
Lomefloxacin—Constipation—Epirubicin—breast cancer	1.97e-05	0.000128	CcSEcCtD
Lomefloxacin—Nausea—Capecitabine—breast cancer	1.97e-05	0.000128	CcSEcCtD
Lomefloxacin—Urticaria—Methotrexate—breast cancer	1.96e-05	0.000127	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—COMT—breast cancer	1.95e-05	0.000307	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—breast cancer	1.95e-05	0.000307	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—breast cancer	1.95e-05	0.000307	CbGpPWpGaD
Lomefloxacin—Abdominal pain—Methotrexate—breast cancer	1.95e-05	0.000127	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.95e-05	0.000127	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—GSTP1—breast cancer	1.95e-05	0.000306	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—breast cancer	1.94e-05	0.000305	CbGpPWpGaD
Lomefloxacin—Insomnia—Doxorubicin—breast cancer	1.93e-05	0.000126	CcSEcCtD
Lomefloxacin—CYP1A2—Metapathway biotransformation—COMT—breast cancer	1.93e-05	0.000303	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HADHB—breast cancer	1.92e-05	0.000302	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—GSTP1—breast cancer	1.92e-05	0.000302	CbGpPWpGaD
Lomefloxacin—Paraesthesia—Doxorubicin—breast cancer	1.92e-05	0.000125	CcSEcCtD
Lomefloxacin—Dyspnoea—Doxorubicin—breast cancer	1.9e-05	0.000124	CcSEcCtD
Lomefloxacin—Feeling abnormal—Epirubicin—breast cancer	1.9e-05	0.000124	CcSEcCtD
Lomefloxacin—Somnolence—Doxorubicin—breast cancer	1.9e-05	0.000123	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Epirubicin—breast cancer	1.89e-05	0.000123	CcSEcCtD
Lomefloxacin—Dyspepsia—Doxorubicin—breast cancer	1.88e-05	0.000122	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—HMOX1—breast cancer	1.87e-05	0.000294	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—RB1—breast cancer	1.86e-05	0.000292	CbGpPWpGaD
Lomefloxacin—Decreased appetite—Doxorubicin—breast cancer	1.86e-05	0.000121	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—IL6—breast cancer	1.84e-05	0.00029	CbGpPWpGaD
Lomefloxacin—Fatigue—Doxorubicin—breast cancer	1.84e-05	0.00012	CcSEcCtD
Lomefloxacin—Urticaria—Epirubicin—breast cancer	1.83e-05	0.000119	CcSEcCtD
Lomefloxacin—Constipation—Doxorubicin—breast cancer	1.83e-05	0.000119	CcSEcCtD
Lomefloxacin—Abdominal pain—Epirubicin—breast cancer	1.82e-05	0.000119	CcSEcCtD
Lomefloxacin—Hypersensitivity—Methotrexate—breast cancer	1.82e-05	0.000118	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ABCB1—breast cancer	1.79e-05	0.000282	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—GSTM1—breast cancer	1.79e-05	0.000281	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.77e-05	0.000279	CbGpPWpGaD
Lomefloxacin—Asthenia—Methotrexate—breast cancer	1.77e-05	0.000115	CcSEcCtD
Lomefloxacin—CYP1A2—Metapathway biotransformation—GSTM1—breast cancer	1.76e-05	0.000277	CbGpPWpGaD
Lomefloxacin—Feeling abnormal—Doxorubicin—breast cancer	1.76e-05	0.000114	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—FHL2—breast cancer	1.76e-05	0.000277	CbGpPWpGaD
Lomefloxacin—Gastrointestinal pain—Doxorubicin—breast cancer	1.75e-05	0.000114	CcSEcCtD
Lomefloxacin—Pruritus—Methotrexate—breast cancer	1.74e-05	0.000113	CcSEcCtD
Lomefloxacin—Hypersensitivity—Epirubicin—breast cancer	1.7e-05	0.000111	CcSEcCtD
Lomefloxacin—Urticaria—Doxorubicin—breast cancer	1.7e-05	0.00011	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—CYP1A1—breast cancer	1.69e-05	0.000267	CbGpPWpGaD
Lomefloxacin—Abdominal pain—Doxorubicin—breast cancer	1.69e-05	0.00011	CcSEcCtD
Lomefloxacin—Diarrhoea—Methotrexate—breast cancer	1.69e-05	0.00011	CcSEcCtD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP1A1—breast cancer	1.67e-05	0.000263	CbGpPWpGaD
Lomefloxacin—Asthenia—Epirubicin—breast cancer	1.66e-05	0.000108	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—breast cancer	1.65e-05	0.000259	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	1.63e-05	0.000257	CbGpPWpGaD
Lomefloxacin—Pruritus—Epirubicin—breast cancer	1.63e-05	0.000106	CcSEcCtD
Lomefloxacin—Dizziness—Methotrexate—breast cancer	1.63e-05	0.000106	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—breast cancer	1.62e-05	0.000254	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	1.58e-05	0.000249	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MDM2—breast cancer	1.58e-05	0.000249	CbGpPWpGaD
Lomefloxacin—Diarrhoea—Epirubicin—breast cancer	1.58e-05	0.000103	CcSEcCtD
Lomefloxacin—Hypersensitivity—Doxorubicin—breast cancer	1.57e-05	0.000102	CcSEcCtD
Lomefloxacin—Vomiting—Methotrexate—breast cancer	1.57e-05	0.000102	CcSEcCtD
Lomefloxacin—Rash—Methotrexate—breast cancer	1.55e-05	0.000101	CcSEcCtD
Lomefloxacin—Dermatitis—Methotrexate—breast cancer	1.55e-05	0.000101	CcSEcCtD
Lomefloxacin—Headache—Methotrexate—breast cancer	1.54e-05	0.0001	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—breast cancer	1.54e-05	0.000243	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—breast cancer	1.53e-05	0.000241	CbGpPWpGaD
Lomefloxacin—Asthenia—Doxorubicin—breast cancer	1.53e-05	9.96e-05	CcSEcCtD
Lomefloxacin—Dizziness—Epirubicin—breast cancer	1.53e-05	9.92e-05	CcSEcCtD
Lomefloxacin—Pruritus—Doxorubicin—breast cancer	1.51e-05	9.82e-05	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—breast cancer	1.49e-05	0.000235	CbGpPWpGaD
Lomefloxacin—Vomiting—Epirubicin—breast cancer	1.47e-05	9.54e-05	CcSEcCtD
Lomefloxacin—Nausea—Methotrexate—breast cancer	1.46e-05	9.52e-05	CcSEcCtD
Lomefloxacin—Diarrhoea—Doxorubicin—breast cancer	1.46e-05	9.5e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX2—breast cancer	1.46e-05	0.000229	CbGpPWpGaD
Lomefloxacin—Rash—Epirubicin—breast cancer	1.46e-05	9.46e-05	CcSEcCtD
Lomefloxacin—Dermatitis—Epirubicin—breast cancer	1.45e-05	9.45e-05	CcSEcCtD
Lomefloxacin—Headache—Epirubicin—breast cancer	1.45e-05	9.4e-05	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—CDKN1B—breast cancer	1.45e-05	0.000227	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—breast cancer	1.44e-05	0.000226	CbGpPWpGaD
Lomefloxacin—Dizziness—Doxorubicin—breast cancer	1.41e-05	9.18e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—breast cancer	1.41e-05	0.000221	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—RAF1—breast cancer	1.39e-05	0.000218	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CCND1—breast cancer	1.38e-05	0.000217	CbGpPWpGaD
Lomefloxacin—Nausea—Epirubicin—breast cancer	1.37e-05	8.91e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism—SYNJ2—breast cancer	1.36e-05	0.000214	CbGpPWpGaD
Lomefloxacin—Vomiting—Doxorubicin—breast cancer	1.36e-05	8.83e-05	CcSEcCtD
Lomefloxacin—Rash—Doxorubicin—breast cancer	1.35e-05	8.75e-05	CcSEcCtD
Lomefloxacin—Dermatitis—Doxorubicin—breast cancer	1.35e-05	8.75e-05	CcSEcCtD
Lomefloxacin—Headache—Doxorubicin—breast cancer	1.34e-05	8.7e-05	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—CDKN1A—breast cancer	1.33e-05	0.00021	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—breast cancer	1.27e-05	0.0002	CbGpPWpGaD
Lomefloxacin—Nausea—Doxorubicin—breast cancer	1.27e-05	8.25e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism—NDUFS3—breast cancer	1.27e-05	0.000199	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—MYC—breast cancer	1.24e-05	0.000195	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—MED12—breast cancer	1.22e-05	0.000192	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CHST9—breast cancer	1.19e-05	0.000187	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	1.16e-05	0.000183	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MAPK3—breast cancer	1.14e-05	0.000179	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	1.13e-05	0.000178	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—COX11—breast cancer	1.13e-05	0.000178	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ALB—breast cancer	1.12e-05	0.000176	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	1.11e-05	0.000175	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MYC—breast cancer	1.11e-05	0.000174	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—breast cancer	1.08e-05	0.000169	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SHMT1—breast cancer	1.03e-05	0.000163	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CDA—breast cancer	1.03e-05	0.000163	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	1.02e-05	0.00016	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—RAF1—breast cancer	1.01e-05	0.000159	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	1.01e-05	0.000159	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLCO1B1—breast cancer	9.95e-06	0.000156	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC2A5—breast cancer	9.95e-06	0.000156	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	9.72e-06	0.000153	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—APRT—breast cancer	9.61e-06	0.000151	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—FASN—breast cancer	9.43e-06	0.000148	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—breast cancer	9.39e-06	0.000148	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—TP53—breast cancer	9.08e-06	0.000143	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ANGPTL4—breast cancer	9.03e-06	0.000142	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ESRRA—breast cancer	9.03e-06	0.000142	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	8.59e-06	0.000135	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GPI—breast cancer	8.56e-06	0.000135	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HADHB—breast cancer	8.56e-06	0.000135	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	8.19e-06	0.000129	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALDH7A1—breast cancer	8.17e-06	0.000128	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALDH1A1—breast cancer	8.17e-06	0.000128	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	8.07e-06	0.000127	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—UMPS—breast cancer	7.83e-06	0.000123	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NME1—breast cancer	7.83e-06	0.000123	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—FHL2—breast cancer	7.83e-06	0.000123	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ADSL—breast cancer	7.83e-06	0.000123	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PHGDH—breast cancer	7.83e-06	0.000123	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—BRIP1—breast cancer	7.68e-06	0.000121	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—LDHB—breast cancer	7.68e-06	0.000121	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HPSE—breast cancer	7.68e-06	0.000121	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTA3—breast cancer	7.28e-06	0.000114	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HMMR—breast cancer	7.28e-06	0.000114	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ABCC1—breast cancer	7.28e-06	0.000114	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PPARGC1B—breast cancer	7.05e-06	0.000111	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	6.87e-06	0.000108	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	6.87e-06	0.000108	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTA4—breast cancer	6.66e-06	0.000105	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CA9—breast cancer	6.66e-06	0.000105	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	6.57e-06	0.000103	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	6.51e-06	0.000102	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GPX2—breast cancer	6.49e-06	0.000102	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTA2—breast cancer	6.49e-06	0.000102	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SULT1A1—breast cancer	6.41e-06	0.000101	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GPX4—breast cancer	6.41e-06	0.000101	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTA1—breast cancer	6.26e-06	9.85e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—IDH1—breast cancer	6.26e-06	9.85e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NAT2—breast cancer	6.19e-06	9.74e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	5.6e-06	8.8e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—DPYD—breast cancer	5.43e-06	8.54e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—MED12—breast cancer	5.43e-06	8.54e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALDOA—breast cancer	5.34e-06	8.4e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NCOA3—breast cancer	5.19e-06	8.16e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC2A2—breast cancer	5.15e-06	8.1e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	5.1e-06	8.02e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ABCG2—breast cancer	5.05e-06	7.94e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CPT1A—breast cancer	5.05e-06	7.94e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—MTR—breast cancer	5.05e-06	7.94e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HPGDS—breast cancer	4.95e-06	7.78e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HBA1—breast cancer	4.92e-06	7.73e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ACHE—breast cancer	4.8e-06	7.55e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTT1—breast cancer	4.8e-06	7.55e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP17A1—breast cancer	4.54e-06	7.15e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ENO1—breast cancer	4.5e-06	7.07e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PTGS1—breast cancer	4.5e-06	7.07e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.48e-06	7.05e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.42e-06	6.96e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP2D6—breast cancer	4.41e-06	6.94e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NCOA2—breast cancer	4.33e-06	6.81e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—FASN—breast cancer	4.2e-06	6.6e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—BCHE—breast cancer	4.18e-06	6.58e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC5A5—breast cancer	4.13e-06	6.5e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NQO1—breast cancer	3.99e-06	6.27e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC2A1—breast cancer	3.99e-06	6.27e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.91e-06	6.14e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP3A4—breast cancer	3.89e-06	6.12e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.87e-06	6.09e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP1B1—breast cancer	3.82e-06	6.01e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HSP90AA1—breast cancer	3.75e-06	5.9e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NCOA1—breast cancer	3.65e-06	5.74e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—STK11—breast cancer	3.6e-06	5.65e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP19A1—breast cancer	3.6e-06	5.65e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.38e-06	5.31e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—COMT—breast cancer	3.34e-06	5.26e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTP1—breast cancer	3.33e-06	5.23e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HMOX1—breast cancer	3.28e-06	5.16e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ITPR1—breast cancer	3.27e-06	5.15e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ABCB1—breast cancer	3.15e-06	4.95e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—TYMS—breast cancer	3.09e-06	4.86e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTM1—breast cancer	3.06e-06	4.81e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NCOR1—breast cancer	3.06e-06	4.81e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PLA2G4A—breast cancer	3.06e-06	4.81e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GPX1—breast cancer	2.93e-06	4.6e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP1A1—breast cancer	2.9e-06	4.56e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ERCC2—breast cancer	2.87e-06	4.52e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—MTHFR—breast cancer	2.7e-06	4.25e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CAV1—breast cancer	2.49e-06	3.92e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.38e-06	3.74e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CG—breast cancer	2.27e-06	3.57e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CD—breast cancer	2e-06	3.14e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALB—breast cancer	1.97e-06	3.1e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NOS3—breast cancer	1.88e-06	2.96e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CB—breast cancer	1.74e-06	2.74e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PTGS2—breast cancer	1.72e-06	2.71e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PTEN—breast cancer	1.5e-06	2.36e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CA—breast cancer	1.06e-06	1.67e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AKT1—breast cancer	8.66e-07	1.36e-05	CbGpPWpGaD
